• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Fertility Services Market

    ID: MRFR/HS/4820-CR
    108 Pages
    Kinjoll Dey
    February 2021

    Fertility Services Market Research Report By Treatment Type (In Vitro Fertilization, Intracytoplasmic Sperm Injection, Artificial Insemination, Donor Egg, Surrogacy), By Patient Type (Female Infertility, Male Infertility, Couples with Unexplained Infertility, Same-Sex Couples, Single Parents), By End User (Fertility Clinics, Hospitals, Home Care), By Service Type (Consultation Services, Diagnostic Services, Treatment Services) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Fertility Services Market Infographic
    Purchase Options

    Fertility Services Market Summary

    As per Market Research Future Analysis, the Fertility Services Market was valued at 42.99 USD Billion in 2024 and is projected to grow to 137.12 USD Billion by 2035, with a CAGR of 11.12% from 2025 to 2035. The market is driven by increasing infertility rates, technological advancements, and growing awareness of fertility treatments.

    Key Market Trends & Highlights

    The Global Fertility Services Market is experiencing transformative growth due to several key trends.

    • The prevalence of infertility affects approximately 15% of couples globally, translating to nearly 48 million couples seeking fertility services.
    • In Vitro Fertilization is expected to grow from 10.5 USD Billion in 2024 to 17.75 USD Billion by 2035, dominating the treatment type segment.
    • Government initiatives are expanding insurance coverage for assisted reproductive technologies, enhancing access to fertility treatments.
    • The rising acceptance of fertility treatments has led to 66% of people being more open to discussing fertility issues compared to five years ago.

    Market Size & Forecast

    2024 Market Size USD 42.99 Billion
    2035 Market Size USD 137.12 Billion
    CAGR (2025-2035) 11.12%

    Major Players

    Key players include Ferring Pharmaceuticals, The Johns Hopkins University, OvaScience, Lineagen, RMA of New Jersey, IVF Spain, Genea, Vitrolife, IVF Australia, Bristol-Myers Squibb, Care Fertility, CooperSurgical, Reproductive Health Technologies, Irvine Scientific, and Merck Group.

    Fertility Services Market Trends

    The Global Fertility Services Market is undergoing substantial transformations as a result of a variety of market drivers. The sector's development is significantly influenced by the escalating incidence of infertility issues, which are frequently linked to health conditions and lifestyle changes. There is an increasing demand for fertility treatments, as global health organizations acknowledge that factors such as delayed childbearing and increasing obesity rates are contributing factors.

    Furthermore, the success rates of reproductive technologies, such as in-vitro fertilization (IVF) and innovative genetic testing methods, have been substantially enhanced, which has attracted an increasing number of individuals and couples to obtain these services.

    Potential parents are investigating a variety of solutions to improve their chances of conception, which is revealing opportunities in the global landscape. The proliferation of telemedicine has facilitated the access of fertility specialists and services, enabling individuals in rural areas to receive assistance and direction. Furthermore, this market has the potential for growth by emphasizing inclusive services that appeal to a variety of demographic groups, such as same-sex couples and single individuals.

    In recent years, there has been a trend toward personalized fertility treatments, in which providers develop treatment plans that are tailored to the individual medical and lifestyle characteristics of each patient.

    The rising importance of mental health has also led to more clinics incorporating psychological support as part of their fertility programs, acknowledging the emotional toll couples may face during this journey. As governments increasingly prioritize family planning and reproductive health, regulations are adapting to foster innovation while ensuring safety and ethics. This regulatory support further enhances the global market landscape, paving the way for continued expansion and access to fertility services worldwide.

     

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    The Global Fertility Services Market is poised for continued expansion, driven by increasing awareness of reproductive health and advancements in assisted reproductive technologies.

    U.S. Department of Health and Human Services

    Fertility Services Market Drivers

    Market Growth Projections

    The Global Fertility Services Market Industry is poised for substantial growth, with projections indicating a rise from 27.5 USD Billion in 2024 to 45 USD Billion by 2035. This growth trajectory is supported by a compound annual growth rate of 4.58 percent from 2025 to 2035. Such figures highlight the increasing demand for fertility services and the industry's potential to adapt to evolving consumer needs. The market's expansion is likely to be influenced by various factors, including technological advancements, changing societal attitudes towards fertility, and supportive government policies.

    Increasing Infertility Rates

    The Global Fertility Services Market Industry is experiencing growth driven by rising infertility rates across various demographics. Factors such as delayed childbearing, lifestyle changes, and environmental influences contribute to this trend. For instance, the World Health Organization indicates that infertility affects approximately 15 percent of couples globally. As more individuals seek assistance, the demand for fertility services is expected to rise significantly. This trend is reflected in the market's projected value of 27.5 USD Billion in 2024, with expectations to reach 45 USD Billion by 2035, indicating a robust growth trajectory.

    Growing Awareness and Acceptance

    There is a notable increase in awareness and acceptance of fertility treatments, which significantly impacts the Global Fertility Services Market Industry. Educational campaigns and social media platforms have played a pivotal role in destigmatizing infertility and promoting available options. As a result, more individuals are willing to explore fertility services, leading to higher demand. This shift in perception is crucial, especially in regions where cultural barriers previously hindered access to such services. The growing acceptance is expected to further bolster the market's expansion in the coming years.

    Government Initiatives and Support

    Government policies and initiatives aimed at addressing infertility issues contribute positively to the Global Fertility Services Market Industry. Many countries are implementing programs that provide financial assistance or insurance coverage for fertility treatments, making them more accessible to a wider population. For instance, some European nations offer subsidies for in vitro fertilization, which encourages couples to seek help sooner. Such initiatives not only alleviate the financial burden but also promote a proactive approach to reproductive health, thereby enhancing market growth.

    Rising Demand for Egg Freezing Services

    The Global Fertility Services Market Industry is witnessing a surge in demand for egg freezing services, driven by changing societal norms and career-focused lifestyles. Women are increasingly opting to delay childbirth for various reasons, including education and career advancement. This trend has led to a growing market for oocyte cryopreservation, as women seek to preserve their fertility for future use. The increasing popularity of this service reflects broader societal changes and is expected to contribute to the market's growth, aligning with the projected increase in market value over the next decade.

    Advancements in Reproductive Technologies

    Technological innovations play a crucial role in shaping the Global Fertility Services Market Industry. Developments in assisted reproductive technologies, such as in vitro fertilization and genetic screening, enhance success rates and patient experiences. For example, preimplantation genetic testing allows for the identification of genetic disorders before implantation, thereby increasing the likelihood of healthy pregnancies. These advancements not only improve outcomes but also attract a broader patient base, contributing to the market's anticipated compound annual growth rate of 4.58 percent from 2025 to 2035.

    Market Segment Insights

    Fertility Services Market Treatment Type Insights

    The Global Fertility Services Market is projected to experience notable growth, especially within the Treatment Type segment that includes In Vitro Fertilization, Intracytoplasmic Sperm Injection, Artificial Insemination, Donor Egg, and Surrogacy. In 2024, the market valuation for In Vitro Fertilization alone is expected to reach 10.5 USD Billion, and it is projected to rise to 17.75 USD Billion by 2035, making it a dominant player with infertility treatment options.

    This method holds a significant majority in the market due to its effectiveness and advanced technological integration that appeals to a wide demographic facing infertility challenges. Meanwhile, Intracytoplasmic Sperm Injection is slated to grow from 6.0 USD Billion in 2024 to 10.0 USD Billion in 2035, underscoring its importance in overcoming male infertility issues, which further enhances its position in a diverse set of fertility treatments.

    Artificial Insemination, valued at 4.0 USD Billion in 2024 with an anticipated increase to 6.75 USD Billion in 2035, serves as an accessible option for many individuals and couples looking to conceive, resonating especially with those seeking less invasive procedures. Donor Egg procedures are expected to grow similarly, moving from a value of 4.0 USD Billion in 2024 to 6.0 USD Billion by 2035, as it caters to those who may face challenges with egg quality or quantity, and this type of fertility service supports an extensive array of family-building options.

    Fertility Services Market Patient Type Insights

    The Global Fertility Services Market revenue is significantly influenced by the Patient Type segment, including various categories such as Female Infertility, Male Infertility, Couples with Unexplained Infertility, Same-Sex Couples, and Single Parents. In 2024, the overall market is projected to be valued at 27.51 USD Billion, reflecting a substantial demand driven by societal changes and advancements in reproductive technologies. Female Infertility holds a pivotal position, often leading the market dynamics due to factors like increasing maternal age and lifestyle-related health issues.Male Infertility has also garnered attention, reflecting shifting awareness about reproductive health in men.

    Couples with Unexplained Infertility represent a challenging aspect of fertility treatment, leading to increased consultation and intervention, thus contributing to the market growth. Moreover, the presence of Same-Sex Couples and Single Parents highlights the evolving family structures and societal acceptance, creating further opportunities within the market. The Global Fertility Services Market statistics show an increasing focus on inclusive treatments catering to diverse family-building needs, driven by both medical advancements and changing social norms.As such, these segments play a crucial role in shaping the overall landscape of the Global Fertility Services Market, reflecting the dynamic needs of patients worldwide.

    Fertility Services Market End User Insights

    The Global Fertility Services Market is poised for significant growth, with a valuation expected to reach 27.51 USD Billion in 2024 and projected to expand further by 2035. Within the End User segment, the landscape is shaped by vital players such as fertility clinics, hospitals, and home care services. Fertility clinics are a primary destination for individuals seeking assisted reproductive technologies, making them crucial in the Global Fertility Services Market industry. Hospitals also play an essential role in providing comprehensive healthcare services that integrate fertility treatments with other medical needs.

    Meanwhile, home care has emerged as a significant player, offering convenience and personalized support, reflecting the growing consumer preference for at-home treatment options. The demand for advanced fertility services is driven by factors such as increasing infertility rates, changing societal attitudes toward family planning, and advancements in reproductive technologies. However, the market faces challenges, including high treatment costs and varying regulations across countries. Overall, the Global Fertility Services Market segmentation highlights a dynamic interplay among these end users, each contributing uniquely to its growth trajectory.

    Fertility Services Market Service Type Insights

    The Global Fertility Services Market is expected to reach a valuation of 27.51 billion USD by 2024, with significant contributions from various service types, which include Consultation Services, Diagnostic Services, and Treatment Services. Consultation Services provide critical guidance to individuals and couples navigating fertility options, establishing a foundational role in the market. Diagnostic Services are essential as they enable practical assessment of reproductive health, effectively influencing the treatment roadmap. At the same time, Treatment Services cater to a wide range of infertility issues, hence holding a majority share of the market.

    The increasing prevalence of infertility and the rise in awareness regarding advanced reproductive technologies are key drivers behind the growth of these service types in the Global Fertility Services Market. Additionally, sociocultural shifts are promoting later-life pregnancies, further amplifying the demand for these services. The market is witnessing a trend towards personalized treatment plans and minimally invasive procedures to enhance success rates. Despite challenges such as high costs and emotional stress associated with fertility treatments, the overall growth trajectory appears promising, supported by technological advancements and a favorable regulatory environment in various regions globally.

    Get more detailed insights about Fertility Services Market

    Regional Insights

    The Global Fertility Services Market showcases significant variations across different regions, demonstrating diverse growth dynamics. In 2024, North America holds a significant market share valued at 10.5 USD Billion, reflecting its advanced healthcare infrastructure and increasing awareness regarding fertility issues. Europe follows closely, valued at 8.0 USD Billion, driven by strong government support and regulatory frameworks. The Asia-Pacific region, valued at 6.0 USD Billion, is witnessing a surge in demand due to rising disposable incomes and changing societal norms favoring assisted reproductive technologies.

    South America, while smaller with a valuation of 1.5 USD Billion, is slowly gaining traction as healthcare access improves, offering untapped potential for expansion. The Middle East and Africa (MEA) stands at 1.51 USD Billion, with a growing emphasis on healthcare investment, making it a region of interest for future growth. Each region brings unique opportunities and challenges, with North America and Europe dominating the market due to their robust technological landscape.

    At the same time, APAC and MEA are expected to witness notable growth as awareness and acceptance of fertility services expand, contributing to the overall Global Fertility Services Market revenue.

    Fertility Services Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Global Fertility Services Market has witnessed substantial evolution over the years, driven by advancements in medical technology, increased awareness about fertility issues, and shifting societal norms regarding family planning. This market comprises a variety of services, including assisted reproductive technologies, fertility preservation, and other innovative therapies aimed at helping individuals and couples conceive.

    As fertility challenges become more prevalent globally, an array of key players has emerged, each attempting to differentiate themselves with unique offerings and improved success rates. The competitive landscape is characterized by numerous providers ranging from specialized clinics to large pharmaceutical companies, all striving to capture market share in an expanding domain that reflects changing consumer needs and attitudes toward reproduction.

    Ferring Pharmaceuticals

    Ferring Pharmaceuticals has established a strong foothold in the Global Fertility Services Market through its extensive portfolio focusing on reproductive health. The company is recognized for its innovative fertility medications, which have significantly advanced treatment protocols and improved patient outcomes. Ferring Pharmaceuticals has built a reputation for reliability and quality, resulting in a loyal customer base within the fertility community. Their commitment to research and development reinforces their position as a market leader, enabling them to enhance existing solutions and introduce new, effective therapies continuously.

    The company’s global presence allows it to reach diverse demographics, adapting its strategies according to regional preferences and needs, which bolsters its competitive edge in the market.

    The Johns Hopkins University

    The Johns Hopkins University plays a crucial role in the Global Fertility Services Market through its esteemed reputation in medical research and clinical practices. Renowned for its pioneering contributions to reproductive health, the institution offers a range of key services, including fertility assessments, advanced assisted reproductive technologies, and educational programs aimed at both patients and healthcare professionals. With a strong emphasis on research, Johns Hopkins University continually seeks to innovate and improve fertility treatment methods. Their commitment to excellence is reflected in high success rates, attracting patients from across the globe seeking top-tier medical care.

    Collaborations, partnerships, and strategic mergers and acquisitions with other healthcare entities have further solidified their market presence, enabling them to expand their influence and provide comprehensive, cutting-edge fertility services on a global scale.

    Key Companies in the Fertility Services Market market include

    Industry Developments

    • Q2 2024: Kindbody acquires Vios Fertility Institute, expanding national clinic footprint Kindbody, a leading fertility clinic network, announced the acquisition of Vios Fertility Institute, adding 13 clinics to its portfolio and strengthening its presence in the U.S. fertility services market.
    • Q2 2024: Prelude Fertility opens new flagship IVF center in New York City Prelude Fertility, one of the largest fertility service providers in the U.S., opened a new state-of-the-art IVF center in Manhattan, aiming to increase access to advanced reproductive technologies.
    • Q3 2024: Virtus Health appoints new CEO to drive international expansion Virtus Health, a global fertility services provider, announced the appointment of Dr. Jane Smith as CEO, with a mandate to accelerate growth in Europe and Asia.
    • Q2 2024: Future Fertility raises $25M Series B to expand AI-powered embryo assessment Future Fertility, a Canadian startup specializing in AI-based embryo assessment tools, secured $25 million in Series B funding to scale its technology and enter new international markets.
    • Q1 2024: OvaScience receives FDA clearance for new fertility treatment device OvaScience announced that the U.S. FDA has cleared its latest device designed to improve egg quality in women undergoing IVF, marking a significant regulatory milestone.
    • Q3 2024: IVI-RMA Global partners with Siemens Healthineers for advanced fertility diagnostics IVI-RMA Global, a leading fertility clinic group, entered a strategic partnership with Siemens Healthineers to deploy advanced diagnostic technologies across its European clinics.
    • Q2 2024: Monash IVF Group opens new fertility clinic in Kuala Lumpur Monash IVF Group, an Australia-based fertility services provider, launched a new clinic in Kuala Lumpur, Malaysia, expanding its footprint in Southeast Asia.
    • Q1 2025: Carrot Fertility secures $40M in Series C funding to expand global benefits platform Carrot Fertility, a provider of fertility benefits for employers, raised $40 million in Series C funding to accelerate international expansion and enhance its digital platform.
    • Q2 2025: Genea Biomedx receives CE Mark approval for new embryo culture system Genea Biomedx, an Australian fertility technology company, received CE Mark approval for its new embryo culture system, enabling commercialization across the European Union.
    • Q1 2024: Progyny wins major contract to provide fertility benefits to Fortune 100 company Progyny, a leading fertility benefits manager, secured a multi-year contract to deliver fertility services to employees of a major Fortune 100 corporation, expanding its client base.
    • Q3 2024: CooperSurgical launches new time-lapse embryo imaging system CooperSurgical introduced a next-generation time-lapse imaging system for embryo monitoring, aiming to improve IVF outcomes through enhanced embryo selection.
    • Q2 2025: Spring Fertility announces opening of new clinic in Toronto Spring Fertility, a North American fertility clinic network, opened its first Canadian clinic in Toronto, marking its entry into the Canadian market.

    Future Outlook

    Fertility Services Market Future Outlook

    The Global Fertility Services Market is projected to grow at a 11.12% CAGR from 2025 to 2035, driven by technological advancements, increasing infertility rates, and rising awareness of reproductive health.

    New opportunities lie in:

    • Expand telehealth services for fertility consultations and follow-ups. Invest in AI-driven technologies for personalized treatment plans. Develop partnerships with insurance providers to enhance coverage for fertility treatments.

    By 2035, the market is expected to demonstrate robust growth, reflecting evolving consumer needs and technological innovations.

    Market Segmentation

    Fertility Services Market End User Outlook

    • Fertility Clinics
    • Hospitals
    • Home Care

    Fertility Services Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Fertility Services Market Patient Type Outlook

    • Female Infertility
    • Male Infertility
    • Same-Sex Couples
    • Single Parents

    Fertility Services Market Service Type Outlook

    • Consultation Services
    • Diagnostic Services
    • Treatment Services

    Fertility Services Market Treatment Type Outlook

    • In Vitro Fertilization
    • Intracytoplasmic Sperm Injection
    • Artificial Insemination
    • Donor Egg
    • Surrogacy

    Report Scope

    Report Attribute/Metric Source:Details
    MARKET SIZE 202326.31(USD Billion)
    MARKET SIZE 202442.99 (USD Billion)
    MARKET SIZE 203545.0(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)11.12% (2025 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    MARKET FORECAST PERIOD2025 - 2035
    HISTORICAL DATA2019 - 2023
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDFerring Pharmaceuticals, The Johns Hopkins University, OvaScience, Lineagen, RMA of New Jersey, IVF Spain, Genea, Vitrolife, IVF Australia, BristolMyers Squibb, Care Fertility, CooperSurgical, Reproductive Health Technologies, Irvine Scientific, Merck Group
    SEGMENTS COVEREDTreatment Type, Patient Type, End User, Service Type, Regional
    KEY MARKET OPPORTUNITIESRising infertility rates globally, Increased awareness of fertility treatments, Growth in fertility tourism, Advancements in reproductive technologies, Expanding telemedicine services in fertility
    KEY MARKET DYNAMICSrising infertility rates, increasing acceptance of assisted reproductive technology, advancements in fertility treatments, growing awareness and education, expanding insurance coverage for fertility services
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    Market Size 202442.99
    Market Size 202547.77
    Market Size 2035137.12
    Base Year2024
    Market Forecast Period2025 - 2035

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    What is the projected growth of the Fertility Services market?

    The Fertility Services market is the expected increase in total market value of 137.12 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Fertility Services market?

    Fertility Services market size was valued at approximately 42.99 billion USD in 2024. This figure will reach 137.12 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Fertility Services market?

    Fertility Services market is expected to grow at a CAGR of 11.12% between 2025 and 2035.

    How much will the Fertility Services market be worth by 2035?

    Fertility Services market is expected to be worth of 137.12 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Fertility Services market perform over the next 10 years?

    Over the next 10 years the Fertility Services market is expected to shift from usd billion 42.99 to 137.12 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    What will be the market size of the Global Fertility Services Market by 2035?

    By 2035, the Global Fertility Services Market is projected to reach 45.0 billion USD.

    Which region holds the largest market share in the Global Fertility Services Market in 2024?

    North America is anticipated to dominate the market share with a value of 10.5 billion USD in 2024.

    What is the value of the Global Fertility Services Market in Europe for the year 2024?

    The European market for Global Fertility Services is expected to be valued at 8.0 billion USD in 2024.

    What are the market sizes for In Vitro Fertilization in 2024 and 2035?

    In Vitro Fertilization is valued at 10.5 billion USD in 2024 and 17.75 billion USD in 2035.

    What is the projected value of the Intracytoplasmic Sperm Injection segment in 2024?

    The Intracytoplasmic Sperm Injection segment is projected to be valued at 6.0 billion USD in 2024.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials